Raw material and freight cost escalation
Geopolitical tensions in West Asia have increased raw material, packaging, and freight costs; management noted uncertainty in passing these on to customers.
high · management_commentary
Granules India Ltd — Q4 FY26
Granules India delivered a strong Q4 FY26 with revenue of ₹1,476 crore (+23% YoY), EBITDA of ₹352 crore (+40% YoY), and PAT of ₹202 crore (+33% YoY).
bullish
medium
✓ Verified against BSE filing
Risk Intelligence
Material risks this quarter
Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.
Risks
Gagilapur FDA reinspection timeline uncertainty
Despite completing remediation, the FDA has not scheduled a reinspection; management cannot estimate when it will occur, delaying potential product launches.
medium · analyst_questionPeptide CDMO customer concentration and project dependency
The peptide CDMO business is project-driven with potential quarter-to-quarter volatility; management declined to disclose order book or customer concentration details.
medium · analyst_questionDCDA project commercialization delays
The DCDA pilot plant faced pricing pressure from Chinese competitors; commercialization may be delayed by 2-3 months, with capex of ~₹200 crore.
low · management_commentary